BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 6133895)

  • 41. Differential Thy-1 expression by splenic fibroblasts defines functionally distinct subsets.
    Borrello MA; Phipps RP
    Cell Immunol; 1996 Nov; 173(2):198-206. PubMed ID: 8912877
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Host MHC class I molecules modulate in vivo expression of a NK cell receptor.
    Karlhofer FM; Hunziker R; Reichlin A; Margulies DH; Yokoyama WM
    J Immunol; 1994 Sep; 153(6):2407-16. PubMed ID: 8077656
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo.
    Truitt RL; Shih CY; Lefever AV; Tempelis LD; Andreani M; Bortin MM
    J Immunol; 1983 Oct; 131(4):2050-8. PubMed ID: 6194224
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preparation and characterization of monoclonal antibodies recognizing three distinct differentiation antigens (BL1, BL2, BL3) on human B lymphocytes.
    Wang CY; Azzo W; Al-Katib A; Chiorazzi N; Knowles DM
    J Immunol; 1984 Aug; 133(2):684-91. PubMed ID: 6429242
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The influence of subclinical level of graft versus host reaction on reconstitution of host lymphoid tissues].
    Hirano M
    Hokkaido Igaku Zasshi; 1994 May; 69(3):453-65. PubMed ID: 7927174
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Altered donor and recipient Ly49+ NK cell subsets in allogeneic H-2d --> H-2b and H-2b --> H-2d bone marrow chimeras.
    Korten S; Wilk E; Gessner JE; Meyer D; Schmidt RE
    J Immunol; 1999 Dec; 163(11):5896-905. PubMed ID: 10570275
    [TBL] [Abstract][Full Text] [Related]  

  • 47. H 9/25 monoclonal antibody recognizes a new allospecificity of mouse lymphocyte subpopulations: strain and tissue distribution.
    Takei F; Galfrè G; Alderson T; Lennox ES; Milstein C
    Eur J Immunol; 1980 Apr; 10(4):241-6. PubMed ID: 7398756
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transfection and expression of syngeneic H-2 genes does not reduce malignancy of H-2 negative teratocarcinoma cells in the autologous host.
    Ostrand-Rosenberg S; Cole GA; Nishimura MI; Clements VK
    Cell Immunol; 1990 Jun; 128(1):152-64. PubMed ID: 2344619
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vivo and in vitro cultured mouse preimplantation embryos differ in their display of a teratocarcinoma cell surface antigen: possible binding of an oviduct factor.
    Gaunt SJ
    J Embryol Exp Morphol; 1985 Aug; 88():55-69. PubMed ID: 3908613
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dynamics of lymphocytic subpopulations in Friend leukemia virus-induced leukemia.
    Kitagawa M; Matsubara O; Kasuga T
    Cancer Res; 1986 Jun; 46(6):3034-9. PubMed ID: 2870802
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Thy-1 glycoprotein is expressed in mouse embryonal carcinoma cells P19.
    Dráber P; Malý P; Hausner P; Pokorná Z
    Int J Dev Biol; 1989 Sep; 33(3):369-78. PubMed ID: 2484657
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Surface antigen changes accompanying lymphocyte activation. Selective reactivity of certain anti-H-2 antisera with activated lymphocytes of unrelated H-2 haplotype.
    Kerbel RS
    Scand J Immunol; 1977; 6(10):1029-40. PubMed ID: 303373
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel tumor-specific antigen(s) response observed in a syngeneic lymphoma-bearing host.
    Manson LA
    Cancer Detect Prev Suppl; 1987; 1():111-20. PubMed ID: 3121177
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulation of major histocompatibility gene expression in teratocarcinoma 402AX cells.
    Ostrand-Rosenberg S; Clements V; Cole G; DeCloux A; Marr L; Schwartzman M
    Cell Differ; 1984 Dec; 15(2-4):221-7. PubMed ID: 6336034
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The collaboration of H-2 identical bone marrow cells in in vivo antitumor activity of immune mouse splenocytes.
    Ozawa H; Iwaguchi T; Kataoka T
    Jpn J Cancer Res; 1987 Feb; 78(2):113-6. PubMed ID: 3104253
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lack of demonstrable H-2 antigens on the surface of teratocarcinoma 402AX of the mouse maintained in vivo.
    Isa AM
    Transplantation; 1976 Mar; 21(3):196-8. PubMed ID: 781924
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regulation of Forssman antigen expression during maturation of mouse stromal macrophages in haematopoietic foci.
    Sadahira Y; Yasuda T; Kimoto T
    Immunology; 1991 Aug; 73(4):498-504. PubMed ID: 1916901
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of rabbit cells by monoclonal and polyclonal antibodies.
    Ponsard DC; Cinader B; Chou CT; Dubiski S
    Immunology; 1986 Sep; 59(1):115-22. PubMed ID: 3489667
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Receptors for immune complexes on cells within a non-lymphoid murine tumor.
    Braslawsky GR; Yaackubowicz M; Frensdorff A; Witz IP
    J Immunol; 1976 Jun; 116(6):1571-8. PubMed ID: 1270806
    [TBL] [Abstract][Full Text] [Related]  

  • 60. H-2 class I antigen expression on mouse teratocarcinoma cell lines.
    Démant P; Oudshoorn-Snoek M
    Immunogenetics; 1985; 22(6):543-52. PubMed ID: 4077148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.